<p><b>A</b>: PCR assay for confirmation of recombinant phages. <b>B</b>: Spot assay for testing the ability of PaP1, PaP1-rec1, and JG004 to infect PAO1 and PA1. <b>C</b>: Adsorption assay for testing the specificity of JG004, PaP1, and recombinant PaP1-rec1 in binding to <i>P. aeruginosa</i> strains PA1 and PAO1.</p
Pseudomonas aeruginosa is a ubiquitous organism which has emerged as a major public health threat in...
We isolated a new lytic Pseudomonas aeruginosa phage that requires type IV pili for infection. PA1Ø ...
<p>(A) after surface biopanning round 3 (B) after surface biopanning round 4A and (C) after solution...
<p><b>A</b>: Spot assays for testing host specificity of phages PaP1 and JG004. <b>B</b>: Adsorption...
<p><b>A</b>: Adsorption assay of bacteriophages JG004-m0 and JG004 to <i>P. aeruginosa</i> PA1 and P...
<p>Phage receptor identification on <i>P</i>. <i>aeruginosa</i> PAO1 mutants.</p
<p><b>Spot assay of lytic phages on the lawn of MDR-bacterial isolates</b>. A. Spot assay of phage M...
<div><p>Phage therapy, treating bacterial infections with bacteriophages, could be a future alternat...
Phage therapy, treating bacterial infections with bacteriophages, could be a future alternative to a...
Phages are obligate parasites that kill bacteria through their lytic life cycle. This constant selec...
An important viromics challenge is associating bacteriophages to hosts. To address this, we develope...
Phages could be an important alternative to antibiotics, especially for treatment of multiresistant ...
Pseudomonas aeruginosa is the most prevalent opportunistic bacterial pathogen in hospital-acquired i...
The first step in bacteriophage infection is recognition and binding to the host receptor, which is ...
Adaptation of bacteria to phage predation poses a major obstacle for phage therapy. Bacteria adopt m...
Pseudomonas aeruginosa is a ubiquitous organism which has emerged as a major public health threat in...
We isolated a new lytic Pseudomonas aeruginosa phage that requires type IV pili for infection. PA1Ø ...
<p>(A) after surface biopanning round 3 (B) after surface biopanning round 4A and (C) after solution...
<p><b>A</b>: Spot assays for testing host specificity of phages PaP1 and JG004. <b>B</b>: Adsorption...
<p><b>A</b>: Adsorption assay of bacteriophages JG004-m0 and JG004 to <i>P. aeruginosa</i> PA1 and P...
<p>Phage receptor identification on <i>P</i>. <i>aeruginosa</i> PAO1 mutants.</p
<p><b>Spot assay of lytic phages on the lawn of MDR-bacterial isolates</b>. A. Spot assay of phage M...
<div><p>Phage therapy, treating bacterial infections with bacteriophages, could be a future alternat...
Phage therapy, treating bacterial infections with bacteriophages, could be a future alternative to a...
Phages are obligate parasites that kill bacteria through their lytic life cycle. This constant selec...
An important viromics challenge is associating bacteriophages to hosts. To address this, we develope...
Phages could be an important alternative to antibiotics, especially for treatment of multiresistant ...
Pseudomonas aeruginosa is the most prevalent opportunistic bacterial pathogen in hospital-acquired i...
The first step in bacteriophage infection is recognition and binding to the host receptor, which is ...
Adaptation of bacteria to phage predation poses a major obstacle for phage therapy. Bacteria adopt m...
Pseudomonas aeruginosa is a ubiquitous organism which has emerged as a major public health threat in...
We isolated a new lytic Pseudomonas aeruginosa phage that requires type IV pili for infection. PA1Ø ...
<p>(A) after surface biopanning round 3 (B) after surface biopanning round 4A and (C) after solution...